Category BUSINESS

Long-Acting

Long-Acting Cabenuva from ViiV Healthcare Demonstrates Superior Results to Oral HIV Regimens in NEJM Study

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM ViiV Healthcare, the global specialist HIV company…

Read MoreLong-Acting Cabenuva from ViiV Healthcare Demonstrates Superior Results to Oral HIV Regimens in NEJM Study